Biosyent Inc (TSE:RX) has released an update.
BioSyent Inc., a specialty pharmaceutical company, has announced that their CEO, René Goehrum, will present at the LD Micro Invitational XIV Conference in New York City, with a live-streamed presentation scheduled for April 9th. Alongside the presentation, one-on-one meetings with investors will be available during the conference. The company is known for its focus on acquiring innovative healthcare products and has a growing portfolio of medicines that contribute to patient care.
For further insights into TSE:RX stock, check out TipRanks’ Stock Analysis page.
